MedDataX Logo

Cytokines and Sevoflurane During Surgery

NCT ID: NCT01231477

Last Updated: 2010-11-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-07-31

Study Completion Date

2010-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the present study was to evaluate the effects of anaesthesia with sevoflurane and surgery on cytokines response.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cytokines Inflammatory Sevoflurane

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

anaesthetic techniques, inhalation sevoflurane Cytokines Immune response

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Volunteers

Healthy volunteers not submitted to anesthesia nor surgery.

No interventions assigned to this group

Sevoflurane Group

This group was submitted to inhalational anesthesia with sevoflurane and otorhinolaryngological surgery.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* both gender, ASA I physical status, 18-50 years old, tympanoplasty and septoplasty.

Exclusion Criteria

* Malignant or genetical diseases; diabetes; smoking; elicit drugs, recent RX radiation.
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

Sponsor Role collaborator

UPECLIN HC FM Botucatu Unesp

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jose EB Orosz, MD

Role: PRINCIPAL_INVESTIGATOR

Botucatu Medical School

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Botucatu Medical School

Botucatu, São Paulo, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

JEO4531

Identifier Type: -

Identifier Source: org_study_id